Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHOP-Campath, A Pilot Study of CHOP Plus Campath for the Primary Treatment of ALK-ve Peripheral T Cell Lymphoma [CHOP-CAMPATH]

NCT00562068 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00562068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00562068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHOP-Campath, A Pilot Study of CHOP Plus Campath for the Primary Treatment of ALK-ve Peripheral T Cell Lymphoma [CHOP-CAMPATH]
Lead sponsor
Cancer Research UK
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2007
Completion date
Not reported
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, small intestine cancer